iSpecimen (ISPC) Cost of Revenue (2020 - 2026)

iSpecimen's Cost of Revenue history runs 7 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• In Q1 2026, Cost of Revenue rose 344.29% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $3.3 million (down 21.98% YoY), while the FY2025 annual figure was $2.3 million, down 55.09% from the prior year.
• Cost of Revenue was $1.5 million for Q1 2026 at iSpecimen, up from $1.1 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $1.6 million in Q3 2024 to a low of $204593.0 in Q3 2025.
• Historically, Cost of Revenue has averaged $932281.2 across 5 years, with a median of $962169.0 in 2023.
• The sharpest annual moves came in 2025 and 2026: Cost of Revenue slumped 86.84% in 2025, then soared 344.29% in 2026.
• A 5-year view of Cost of Revenue shows it stood at $914725.0 in 2022, then plunged by 38.46% to $562895.0 in 2023, then jumped by 126.73% to $1.3 million in 2024, then slipped by 11.22% to $1.1 million in 2025, then soared by 36.11% to $1.5 million in 2026.
• The last three Cost of Revenue figures came in at $1.5 million (Q1 2026), $1.1 million (Q4 2025), and $204593.0 (Q3 2025), per Business Quant data.